Log in to save to my catalogue

AVP modulation of the vestibular nucleus via V1b receptors potentially contributes to the developmen...

AVP modulation of the vestibular nucleus via V1b receptors potentially contributes to the developmen...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4676835

AVP modulation of the vestibular nucleus via V1b receptors potentially contributes to the development of motion sickness in rat

About this item

Full title

AVP modulation of the vestibular nucleus via V1b receptors potentially contributes to the development of motion sickness in rat

Publisher

England: BioMed Central Ltd

Journal title

Molecular brain, 2015-12, Vol.8 (1), p.86-86, Article 86

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Arginine vasopressin (AVP) is considered to be an etiologic hormone in motion sickness (MS). The present study was designed to investigate whether individual differences in AVP expression in the paraventricular nucleus (PVN) and in modulation on the vestibular nucleus (VN) are involved in MS. Systemic application or microinjection of AVP into rat V...

Alternative Titles

Full title

AVP modulation of the vestibular nucleus via V1b receptors potentially contributes to the development of motion sickness in rat

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4676835

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4676835

Other Identifiers

ISSN

1756-6606

E-ISSN

1756-6606

DOI

10.1186/s13041-015-0175-1

How to access this item